Practice Areas

Home Practice Areas Corporate / M&A Venture Capital & Venture Debt

Venture Capital & Venture Debt

Recent Company-side work includes advising:

  • Equal 1 Laboratories Ireland Limited on a multi-tranche equity investment and loan conversion
  • Bronto on its seed funding round led by Cercano Management alongside Heavybit and Conviction Capital.
  • Ceroflo Ltd on its investment fundraising round
  • Tines on its $125m Series C fundraising led by Goldman Sachs Alternatives and SoftBank Vision Fund 2 (and previously on Tines’ Series B3, B2, B2 , A2 and A1 rounds)
  • Druid Software on a $20M investment co-led by J2 Ventures and HICO Investment Group with significant participation from industry experts Arthur Patterson, the co-founder of Accel Partners, and serial telecom founder, John Basil Georges
  • Apata on its equity fundraisings
  • Jolt Energy on its €150m investment by InfaRed Capital Partners
  • Oohpod on its equity investments including by BVP and private investors
  • Flipdish on its equity fundraisings including from Tencent and Tiger Global

Recent Investor-side work includes advising:

  • EQT Life Sciences, Fountain Healthcare Partners and Atlantic Bridge Ventures on their participation in funding rounds for  Neurent Medical and LumaVision
  • Hedosophia Management Ltd on its investment in Protex AI
  • MML Growth Capital Partners Ireland Ltd on its investment in the Mail Metrics group to fund its acquisition of Opus 107
  • Towerbrook Capital Partners on its investment in Let’s Get Checked
  • Accel leading the Series A Investments in Nory and Nuitée Travel
  • Atlantic Bridge on the establishment of its venture capital funds and on its venture investments in Vertigenius, Cloudsphere, Equal1, Micron Agritech, and many other portfolio companies.
  • University Bridge Fund on its venture investments including Aylien, Output Sports, Apisprotect, Plasmabound, Proverum and Siren.
  • ACT Venture Capital on the establishment of and investment by a significant number of its funds as well as on several exits.
  • Vivo Capital on its investment in ALX Oncology.

 

  • Structuring new funds
  • Fundraisings
  • Venture capital investments across all sectors, and on
  • Exits.
  • Raising venture capital and/or
  • Raising venture debt